Claraphi Advisory Network’s Bio-Techne TECH Stock Holding History

Claraphi Advisory Network’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,504	Closed	-$394K	–	354
2021 Q2	$394K	Sell	3,504 -120	-3%	-$12.6K	0.12%	202
2021 Q1	$346K	Sell	3,624 -148	-4%	-$13.5K	0.1%	210
2020 Q4	$300K	Sell	3,772 -1,808	-32%	-$131K	0.08%	211
2020 Q3	$346K	Buy	+5,580	New	+$363K	0.13%	161

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Claraphi Advisory Network's TECH Position: Q3 2021 in Review

Claraphi Advisory Network sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 3,504 shares — an estimated $394K sold.

Claraphi Advisory Network first reported a position in TECH in Q3 2020 and held it in 4 quarters. The position peaked at $394K in Q2 2021. 565 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

Claraphi Advisory Network reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
Claraphi Advisory Network sold 3,504 Bio-Techne shares in Q3 2021, an estimated $394K.
Claraphi Advisory Network first reported a position in Bio-Techne in Q3 2020 and held it in 4 quarters.
Claraphi Advisory Network's Bio-Techne position peaked at $394K in Q2 2021.
565 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Claraphi Advisory Network's 13F filing for Q3 2021, filed 15 Nov 2021.